Abstract
Background: Prior to any revascularization procedure for coronary artery disease, it is essential to identify viable myocardium which will likely benefit from it. In such a situation, delayed enhanced cardiac MRI is beneficial.
Methods: Our study consisted of 50 patients with at least a one-month prior history of myocardial infarction (MI), abnormal findings on electrocardiography (ECG), and 2D-echocardiography (2D-ECHO), who were subjected to cardiac MRI performed on a 3T MRI machine. The MRI scans were evaluated for anatomical and especially functional characteristics of the heart, such as wall motion. On late gadolinium enhancement (LGE), the diseased segments were classified into two categories: < 50% LGE (viable) and > 50% LGE (non-viable).
Results: Of the 378 diseased segments detected on LGE, 137 (36.2%) segments showed < 50% LGE and 241 (63.8%) segments showed > 50% LGE. The segments showing < 50% LGE showed normokinesia or hypokinesia, with none of the segments showing akinesia or dyskinesia, whereas the segments showing > 50% LGE showed akinesia or dyskinesia predominantly. This was found to be statistically highly significant (p-value < 0.001).
Conclusion: Delayed enhanced-cardiac magnetic resonance (DE-CMR) imaging in patients with ischemic heart disease (IHD) helps evaluate the severity of the infarcted myocardium by classifying the diseased myocardium into viable and non-viable, as viable myocardium is more likely to regain functional recovery than non-viable myocardium. It also predicts the functional recovery of the myocardium after revascularization therapy.
Keywords: myocardial infarction , myocardial viability, late gadolinium enhancement, coronary revascularization, cardiac mri
Introduction
Cardiovascular disease (CVD) remains the primary cause of mortality worldwide [1]. Indians are affected by CVD at least a decade before the rest of the world [2]. With the introduction of revascularization techniques such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), observations have been made on their effect on the reversibility of left ventricular (LV) dysfunction [3].
However, revascularization will not be helpful for all patients. Echocardiography establishes the hypokinetic or akinetic myocardium as diseased. This diseased myocardium may be stunned and hibernating or fibrosed. The viable myocardium is described as hibernating or stunned. Due to decreased perfusion, it is hypokinetic or akinetic [4].
After adequate revascularization, this hibernating and stunned myocardium is likely to regain normal myocardial activity, whereas the infarcted myocardium is less likely to recover [5-7]. In addition, pre-operative assessment of the infarct size can predict the functional recovery of dysfunctional myocardial segments after coronary revascularization [8-10].
Various techniques are used to assess myocardial viability in patients with ischemic heart disease (IHD). These techniques include echocardiography, 201Tl single-photon emission computed tomography (SPECT), fluoro-2-deoxyglucose (FDG) positron emission tomography (PET), and cardiac MRI.
Cardiac MRI is a non-invasive, non-ionizing technique that is used for the evaluation of progression of infarcted segments, thinning of LV wall, LV volume, LV shape distortion, and compensatory hypertrophy of healthy myocardium [11]. Cardiac MRI also helps to assess the level of perfusion in the tissue (micro-vascular status) [12]. Cardiac MRI offers more spatial and temporal resolution than other modalities. Cine MRI provides dynamic imaging of cardiac wall motion similar to echocardiography but with better endocardial border definition and superior wall motion assessment. Also, cardiac MRI does not involve ionizing radiation, unlike many other modalities like CT [13]. Unlike PET and SPECT, cardiac MRI provides quantitative cardiac viability, function, and perfusion information.
Infarct evaluation using contrast-enhanced CMR is a relatively novel approach. Extracellular contrast material reveals substantial signal strength in the infarcted areas on T1 weighted images. It is most likely that the extracellular contrast agent disperses into the intracellular space due to the breakdown of the myocyte membrane. Chronic infarcts have collagenous scars with increased interstitium between collagen fibers, leading to a higher contrast concentration and hence contrast enhancement [14]. Due to the revolutionary inversion recovery gradient echo sequence, infarcted myocardium may now be observed with much better resolution than spin-echo sequences [15].
In this study, we have highlighted the importance of LGE in delineating viable from non-viable myocardium, which will affect the selection of patients for revascularization procedures and predict the recovery of LV function.
Materials and methods
Patient selection
This was an observational study comprising 50 patients conducted in the radiology department. Before starting the study, an Institutional Ethical Committee (IEC) clearance was obtained at Dr. DY Patil Medical College, Hospital and Research Center, Pune, with approval number IESC/PGS/2019/168.
Patients ranging in age from 20 to 80 years were referred from the department of cardiology with at least a one-month prior history of myocardial infarction (MI), ECG findings of either ST-segment elevation myocardial infarction (STEMI) or non-ST segment elevation myocardial infarction (NSTEMI), abnormal 2D-echocardiography (2D-ECHO) findings, and were medically treated with thrombolysis. Patients who had undergone revascularization therapies like CABG surgery were excluded from the study. A thorough medical history was collected to rule out any potential contraindications to MRI, like metallic objects, pacemakers, and cochlear implants. Written informed consent was obtained from the patients before the MRI. Before the commencement of the MRI scan, each patient was given a brief explanation of the procedure.
Imaging technique
A Magnetom Vida 3T MRI (Siemens, Erlangen, Germany) was used for the MRI evaluation. MRI was performed on patients supine (head first) with optimal placement and body stabilization. A standard Body Array 18 channel coil was used to acquire images. The participants were given light music to reduce the amount of noise in the MRI room. In addition, patients were trained for breath-holding (taking a breath, breathing out, and then not holding breath for 10-15 s).
First, localizer sequences are done in various planes to localize the heart for anatomy and position. Pre-contrast scanning is done for morphology and function. The sequences used for morphology are T2 TRUFI, T2 HASTE Dark Blood, T2 TSE Dark Blood, T1 TSE Dark Blood, T2 STIR Dark Blood while 2 Chamber CINE TRUFI in Long Axis, 4 Chamber CINE TRUFI in Long Axis, CINE TRUFI Retro in Short Axis, CINE LVOT, and CINE RVOT are used to assess cardiac function. Contrast studies are done for perfusion and viability studies with dimeglumine gadopentetate (0.1 mmol/kg body weight). For perfusion, we used the DYNAMIC TRUFI SR EPAT sequence in 50 phases in 2-chamber, 4-chamber, and short-axis for the left side and a 2-chamber view for the right side of the heart. Following viability imaging, TI SCOUT is taken in the short axis after approximately 10 min of contrast injection to assess TI value. This TI value is further used for the delayed TRUFI high-resolution PSIR sequence. Except for CINE imaging, all image acquisitions were electrocardiogram (ECG)-gated (retrospective gating).
The MRI images were analyzed for the structural anatomy of the heart as well as its functional aspect.
Imaging evaluation
The American Heart Association's 17-segment LV model [16] was utilized to identify segments with late gadolinium enhancement (LGE) (Figure 1).
Based on the extent of LGE, we divided the diseased myocardium into segments showing <50% LGE (Figure 2) and >50% LGE (Figure 3) of the myocardial thickness based on visual eyeballing. A total number of diseased segments, the number of segments with less than 50% and the number of segments with more than 50 % enhancement, wall motion abnormalities, and distribution into the three vascular territories were presented as frequencies and proportions. The degree of wall motion abnormality was assessed based on visual "eyeballing" into one of the three categories in increasing order of severity (hypokinesia, akinesia, and dyskinesia). Normal wall motion was labeled as normokinetic. The distribution of segments was done into three vascular territories: left anterior descending (LAD), LCX (left circumflex), and RCA (right coronary) arteries.
Statistical analysis
Data were entered into Microsoft Excel, and statistical analysis was carried out in SPSS software version 17.0 (IBM, Armonk, NY). Qualitative variables like gender, LV clot, and microvascular obstruction (MVO) were presented as frequency and percentages. In addition, age and ejection fraction were categorized and represented as percentages. Bar diagrams and pie charts were used for the graphical representation of data.
The Mann-Whitney U test and Kruskal-Wallis test were used to compare the number of segments diseased between gender and age categories. A Chi-square test was used to compare wall motion abnormality and the degree of LGE.
A p-value of <0.05 was considered statistically significant.
Results
Some 50 patients with 850 myocardial segments and 150 coronary territories were evaluated. Thirty-four (68%) were males; the mean age of the cases was 54.04 years which ranged from 30 to 77 years. The mean ejection fraction was 30.11% (14.7), with a lowest of 12% and a highest of 67%.
On DE-CMR, out of the total 850 segments, 378 segments showed DE-CMR (diseased myocardial segments), while the remaining 472 segments did not show any enhancement (normal myocardial segments).
The number of diseased segments was found to be higher in males than females, which was found to be statistically significant (p-value = 0.02). A comparison of the number of diseased segments in different age groups was statistically not significant (p-value of 0.202).
The diseased segments were divided into those that showed <50% LGE and those that showed >50% LGE (Table 1). Among the segments showing <50% LGE, 52 (38%) segments showed involvement of LAD territory, 43 (31.4%) segments showed involvement of LCX territory, whereas 42 (30.7%) segments showed involvement of RCA territory. Among the segments showing >50% LGE, 178 (73.9%) segments showed involvement of LAD territory, 27 (11.2%) segments showed involvement of LCX territory, whereas 36 (14.9%) segments showed involvement of RCA territory.
Table 1. Distribution of diseased segments.
Diseased segments | Number | Percentage |
Less than 50% LGE | 137 | 36.2 |
More than 50% LGE | 241 | 63.8 |
Total | 378 | 100.0 |
Based on visual eyeballing, out of the 137 segments showing <50% LGE, 121 (88.3%) segments showed hypokinesia, 16 (11.7%) segments showed normal wall motion, and none of the segments showed akinesia or dyskinesia. Out of the 241 segments showing >50% LGE, 14 (5.8%) segments showed hypokinesia, 162 (67.2%) segments showed akinesia, and 65 segments (27%) showed dyskinesia. None of the segments showed normal wall motion. Thus, the segments showing <50% LGE showed normokinesia or hypokinesia, with none showing akinesia or dyskinesia, whereas the segments showing >50% LGE showed akinesia or dyskinesia predominantly. This was found to be statistically highly significant (p-value<0.001). Hence, as the degree of LGE increases, the severity of wall motion abnormality also increases. A segment with <50% LGE is considered a viable segment, whereas a segment with >50% LGE is considered non-viable (Table 2).
Table 2. Comparison of wall motion abnormality and percentage of LGE.
Wall motion abnormality | Less than 50% LGE | More than 50% LGE | ||
n | % | n | % | |
Normokinesia | 16 | 11.7 | 0 | 0 |
Hypokinesia | 121 | 88.3 | 14 | 5.8 |
Akinesia | 0 | 0 | 162 | 67.2 |
Dyskinesia | 0 | 0 | 65 | 27.0 |
Total | 137 | 100.0 | 241 | 100.0 |
Chi-square p value=<0.001 (highly significant) |
Some 10 (20%) cases showed the presence of MVO in the LV wall (Figure 4). Some 18 (36%) of the study subjects were found to have LV clots (Figure 5).
Discussion
Myocardial viability before any revascularization technique is an essential clinical issue in individuals with IHD. Among the different modalities used in assessing myocardial viability, delayed enhanced-cardiac magnetic resonance imaging (DE-MRI) is a well-known MRI method for assessing viability [17]. The purpose of DE-MRI is to generate pictures with a strong contrast between diseased cardiac tissue that accumulates excess gadolinium (after IV treatment) and normal tissue that has a low gadolinium level [18]. The degree of transmural enhancement can predict the outcome of revascularization, which cannot be done effectively by other methods like 2D-ECHO, PET, and SPECT [19-20].
In our study, which involved 50 patients, 36.2% of the diseased segments showed <50% LGE and 63.8% showed >50% LGE, whereas in a similar study by Aggarwal et al. [21], consisting of 40 patients; 80% of the diseased segments showed less than 50% LGE, and 20% of segments showed more than 50% LGE.
The two most important indicators of ventricular function recovery following revascularization operations are the degree of infarct as estimated by LGE and the end-diastolic wall thickness (EDWT) (Figure 6) [21]. According to research by Schinkel et al., segments having LV EDWT < 6 mm rarely exhibited contractile reserve, whereas most of the segments with comparably maintained EDWT of ≥ 6 mm showed contractile reserve [22]. Amado et al. found a strong link between histology and the delayed enhancement approach in an animal model (r2 = 0.94, p = 0.001) [23]. In 2008, Krittayaphong et al. examined the predictive efficacy of LGE and EDWT as measured by MRI in predicting restoration of LV function following CABG. The study revealed that LGE and EDWT are distinct predictors of functional recovery following revascularization. LGE appears to be of greater significance than EDWT [24].
Additionally, some investigations have hypothesized that delayed enhancement can effectively illustrate the amount of infarct, outcome, and occurrence of potential complications following revascularization. In 2016, Lee et al. assessed the effect of delayed gadolinium enhancement on long-term outcomes in patients undergoing CABG and found that the amount of LGE is a significant predictor of unfavorable cardiovascular events, regardless of LV function [25]. Lim et al. reported in 2018 that the amount of myocardial viability as measured by cardiac magnetic resonance LGE appeared to distinguish individuals who benefit differently after CABG [26]. Choi et al. evaluated 24 patients, seven days following satisfactory revascularization. The extent of the transmural infarct was negatively related to the myocardial contractile recovery [27]. Kim et al. conducted the first study of CE-CMR in 50 patients with chronic ischemia. The amount of diseased but viable myocardium proper to revascularization was related to more extensive improvements in wall motion and ejection fraction post-revascularization [28].
There were 10 (20%) study subjects in which microvascular obstruction (MVO) was detected in our study. In addition, these patients had severe LV systolic dysfunction. In the setting of acute MI, MVO may occur, which is a "no-reflow" process, indicating an inability to reperfuse a section of myocardium despite re-establishment of patency of epicardial coronary arteries. MVO is seen on MRI as a dark, non-enhancing region of the myocardium in both early and delayed enhancement [20]. Microvascular blockage implies significant ischemia (typically transmural) and is linked to a worse prognosis, adverse remodeling [29].
Conclusions
Cardiac MRI is one of the most accurate tools in a radiologist's arsenal for assessing ventricular mass and volumes, aberrations of the wall motion, and ventricular function, both systolic and diastolic. With the use of DE-CMR in patients with IHD, it is possible to know the severity and extent of the infarcted myocardium, classifying the diseased myocardium into viable and non-viable, which helps with patient selection for revascularization therapy as viable myocardium is more likely to regain functional recovery after revascularization than non-viable myocardium.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study. Institutional ethics sub-committee, Dr. DY Patil Medical College, Hospital and Research Centre, Pune issued approval IESC/PGS/2019/168
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Virani SS, Alonso A, Benjamin EJ, et al. Circulation. 2020;141:0. doi: 10.1161/CIR.0000000000000757. [DOI] [PubMed] [Google Scholar]
- 2.Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Xavier D, Pais P, Devereaux PJ, et al. Lancet. 2008;371:1435–1442. doi: 10.1016/S0140-6736(08)60623-6. [DOI] [PubMed] [Google Scholar]
- 3.Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. Velazquez EJ, Lee KL, Jones RH, et al. N Engl J Med. 2016;374:1511–1520. doi: 10.1056/NEJMoa1602001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. Allman Allman, KC KC, Shaw LJ, Hachamovitch R, Udelson JE. J Am Coll Cardiol. 2002;39:1151–1158. doi: 10.1016/s0735-1097(02)01726-6. [DOI] [PubMed] [Google Scholar]
- 5.Predicting benefit from revascularization in patients with ischemic heart failure: imaging of myocardial ischemia and viability. Buckley O, Di Carli M. Circulation. 2011;123:444–450. doi: 10.1161/CIRCULATIONAHA.109.903369. [DOI] [PubMed] [Google Scholar]
- 6.Management of heart failure: III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. https://pubmed.ncbi.nlm.nih.gov/7966846/ JAMA. 1994;272:1528–1534. doi: 10.1001/jama.272.19.1528. [DOI] [PubMed] [Google Scholar]
- 7.New technology for noninvasive evaluation of coronary artery disease. Di Carli MF, Hachamovitch R. Circulation. 2007;115:1464–1480. doi: 10.1161/CIRCULATIONAHA.106.629808. [DOI] [PubMed] [Google Scholar]
- 8.Impact of coronary revascularization and transmural extent of scar on regional left ventricular remodelling. Chan J, Khafagi F, Young AA, Cowan BR, Thompson C, Marwick TH. Eur Heart J. 2008;29:1608–1617. doi: 10.1093/eurheartj/ehn247. [DOI] [PubMed] [Google Scholar]
- 9.Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization. Gutberlet M, Fröhlich M, Mehl S, et al. Eur Radiol. 2005;15:872–880. doi: 10.1007/s00330-005-2653-9. [DOI] [PubMed] [Google Scholar]
- 10.Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. Mahrholdt H, Wagner A, Parker M, et al. J Am Coll Cardiol. 2003;42:505–512. doi: 10.1016/s0735-1097(03)00714-9. [DOI] [PubMed] [Google Scholar]
- 11.Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Sutton MG, Sharpe N. Circulation. 2000;101:2981–2988. doi: 10.1161/01.cir.101.25.2981. [DOI] [PubMed] [Google Scholar]
- 12.Variation on a theme: CMR as the "one-stop shop" for risk stratification after infarction? Wu KC. JACC Cardiovasc Imaging. 2009;2:843–845. doi: 10.1016/j.jcmg.2009.02.013. [DOI] [PubMed] [Google Scholar]
- 13.Patient-centered imaging: shared decision making for cardiac imaging procedures with exposure to ionizing radiation. Einstein AJ, Berman DS, Min JK, et al. J Am Coll Cardiol. 2014;63:1480–1489. doi: 10.1016/j.jacc.2013.10.092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cardiovascular MRI for detection of myocardial viability and ischaemia. Mahrholdt H, Klem I, Sechtem U. Heart. 2007;93:122–129. doi: 10.1136/hrt.2005.071290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.An improved MR imaging technique for the visualization of myocardial infarction. Simonetti OP, Kim RJ, Fieno DS, et al. Radiology. 2001;218:215–223. doi: 10.1148/radiology.218.1.r01ja50215. [DOI] [PubMed] [Google Scholar]
- 16.Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Circulation. 2002;105:539–542. doi: 10.1161/hc0402.102975. [DOI] [PubMed] [Google Scholar]
- 17.Late gadolinium enhancement imaging in assessment of myocardial viability: techniques and clinical applications. Jimenez Juan L, Crean AM, Wintersperger BJ. https://pubmed.ncbi.nlm.nih.gov/25727002/ Radiol Clin North Am. 2015;53:397–411. doi: 10.1016/j.rcl.2014.11.004. [DOI] [PubMed] [Google Scholar]
- 18.Cardiac MR for the assessment of myocardial viability. Van Assche LM, Kim HW, Kim RJ. Methodist Debakey Cardiovasc J. 2013;9:163–168. doi: 10.14797/mdcj-9-3-163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, et al. Circulation. 1999;100:1992–2002. doi: 10.1161/01.cir.100.19.1992. [DOI] [PubMed] [Google Scholar]
- 20.MR imaging of myocardial infarction. Rajiah P, Desai MY, Kwon D, Flamm SD. Radiographics. 2013;33:1383–1412. doi: 10.1148/rg.335125722. [DOI] [PubMed] [Google Scholar]
- 21.Myocardial viability imaging using a novel non-breath-hold cardiac MRI protocol: a comparative assessment with 18 F-FDG PET. Aggarwal R, Singla G, Singh H, George RA, Mukhopadhyay I. Egypt J Radiol Nucl Med. 2020;51:1–8. [Google Scholar]
- 22.Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction. Schinkel AF, Bax JJ, Boersma E, Elhendy A, Vourvouri EC, Roelandt JR, Poldermans D. Am Heart J. 2002;144:865–869. doi: 10.1067/mhj.2002.125627. [DOI] [PubMed] [Google Scholar]
- 23.Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. Amado LC, Gerber BL, Gupta SN, et al. J Am Coll Cardiol. 2004;44:2383–2389. doi: 10.1016/j.jacc.2004.09.020. [DOI] [PubMed] [Google Scholar]
- 24.Comparison of cardiovascular magnetic resonance of late gadolinium enhancement and diastolic wall thickness to predict recovery of left ventricular function after coronary artery bypass surgery. Krittayaphong R, Laksanabunsong P, Maneesai A, Saiviroonporn P, Udompunturak S, Chaithiraphan V. J Cardiovasc Magn Reson. 2008;10:41. doi: 10.1186/1532-429X-10-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Long-term prognostic value of late gadolinium-enhanced magnetic resonance imaging in patients with and without left ventricular dysfunction undergoing coronary artery bypass grafting. Lee SA, Yoon YE, Kim JE, et al. Am J Cardiol. 2016;118:1647–1654. doi: 10.1016/j.amjcard.2016.08.043. [DOI] [PubMed] [Google Scholar]
- 26.Impact of myocardial viability assessed by cardiac magnetic resonance on survival in patients with severe ischemic left ventricular dysfunction. Lim FY, Yap J, Gao F, Low A, Wang S, Le TT, Tan RS. J Am Coll Cardiol. 2018;71:0. doi: 10.1253/circrep.CR-19-0126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Circulation. 2001;104:1101–1107. doi: 10.1161/hc3501.096798. [DOI] [PubMed] [Google Scholar]
- 28.The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, et al. N Engl J Med. 2000;343:1445–1453. doi: 10.1056/NEJM200011163432003. [DOI] [PubMed] [Google Scholar]
- 29.Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Rogers WJ Jr, Kramer CM, Geskin G, et al. Circulation. 1999;99:744–750. doi: 10.1161/01.cir.99.6.744. [DOI] [PubMed] [Google Scholar]